Table 2 Duration of fever, incidence of additional treatment, and coronary artery outcomes
12H group (n = 19) | 24H group (n = 20) | p value | |
|---|---|---|---|
Duration of fever after treatment initiation, h | 21.0 [5–130] | 21.5 [3–144] | 0.325 |
Non-responder of initial IVIG, n | 7 (36.8) | 6 (30.0) | 0.741 |
Total dose of IVIG, g/kg | 2 [2–6] | 2 [2–6] | 0.623 |
Third-line treatment, n | 4 (21.1) | 1 (5.0) | 0.182 |
Coronary artery abnormalities, n | |||
Day 0 | 1 | 0 | 0.487 |
Day 7 | 1 | 0 | 0.487 |
Day 30 | 0 | 0 | 1.000 |